These studies might help to explain the role of β2AR in the pathogenesis of senile dementia and whether treatment with β2AR antagonists may provide new therapeutic options for the treatment of Alzheimer’s disease. The gene discussed is ADRB2; the disease is early-onset autosomal dominant Alzheimer disease.